CME Group surpassed Wall Street’s expectations for second-quarter earnings on Wednesday, with healthy demand for hedging products fueling a 6.1% jump in the company’s share price.
Even as the earnings report drew positive attention, outgoing CEO Terry Duffy took the opportunity to push back against ongoing concerns about perpetual futures — a type of listed derivative contract that has no expiration date, allowing traders to hold positions indefinitely without having to roll them over.
“Strong business performance has been overshadowed by discussions surrounding perpetual futures,” Duffy told analysts during a post-earnings call.
The exchange posted an adjusted profit of $2.99 per share for the second quarter, topping analyst expectations of $2.91 per share, according to figures compiled by LSEG. That result also edged out the $2.96 per share the company reported during the same period last year — a quarter that had benefited from record trading volumes sparked by U.S. President Donald Trump’s Liberation Day tariff announcements.
In the most recent quarter, ongoing volatility tied to the U.S.-Israeli conflict with Iran and broader Middle East tensions kept markets active, though the boost was more modest compared to last year.
Total average daily volume, or ADV, dipped 1% compared to the prior year, as activity in interest rate and energy contracts declined and metals trading held flat. On the other hand, equity index ADV climbed 13% during the quarter, reflecting investor interest driven by a 14.9% rise in the benchmark S&P 500 index. ADV for both agricultural products and cryptocurrencies also increased in the quarter.
Revenue from the company’s market data and information services division grew 20.2%, while clearing and transaction fee revenue declined 2.6%.
“Overall we view this as a solid quarter for CME on the back of tough 1Q26 & 2Q25 comparisons,” analysts at Piper Sandler wrote in a research note.
Despite the upbeat results, CME’s stock has fallen roughly 8% since the start of the year. Much of that decline has been attributed to investor concern over so-called “perps” — perpetual futures contracts that received regulatory approval on May 29. Some fear these products could chip away at the market share of traditional exchange operators like CME.
Duffy acknowledged that CME has the technical and operational infrastructure in place to offer perpetual futures, but said the company simply hasn’t received customer interest in them. “These products do not appeal to our core customers,” he said.
CME’s stock has lagged behind most of its major competitors this year, with the exception of Intercontinental Exchange, the parent company of the New York Stock Exchange.
Analysts at Raymond James offered an optimistic take on the situation, writing: “We believe the bear case related to perpetual futures will prove to be a non-event for CME, but in the meantime it has created an attractive entry point for CME’s shares.”
Duffy, who has led the derivatives exchange as CEO for roughly a decade, is set to hand over the reins to insider Lynne Fitzpatrick, who will become CME’s first female chief executive on March 1 of next year. The company made that announcement in June.
